Dr. Robin Jones on Olaratumab and Doxorubicin Combination in Patients with Soft Tissue Sarcoma
December 4th 2015Robin Jones, BSc, MB, MRCP, MD, oncologist, Royal Marsden Hospital, London, discusses the effectiveness of monoclonal antibody olaratumab in combination with doxorubicin in metastatic soft tissue sarcoma.